Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NudC domain-containing protein 2 (NUDCD2) is a cytoplasmic protein that participates in protein folding and enables unfolded protein binding. It may regulate the LIS1/dynein pathway by stabilizing LIS1 with Hsp90 chaperone, impacting cell migration and preventing centriole amplification. It is implicated in neural development through potential association with lissencephaly. There is no evidence that NUDCD2 is a conventional therapeutic target (e.g., receptor, enzyme, transporter) nor that it interacts directly with any drugs, serves as a clinical biomarker, or presents known safety concerns. The name is correctly spelled and specific; all common aliases are listed. Its molecular class is best described as “Other,” reflecting its role in protein interaction and cellular regulation, primarily in protein folding and microtubule-associated processes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NudC domain-containing protein 2 (NUDCD2).